New York Blood Center

The New York Blood Center (NYBC) is a community, nonprofit blood bank based in New York City.[1] Established in 1964 by Dr. Aaron Kellner,[2] NYBC supplies blood to approximately 200 hospitals in the Northeast United States.[3] NYBC and its operating divisions also provide transfusion-related medical services to over 500 hospitals nationally.

New York Blood Center
Founded1964 (1964)
TypeBlood bank
131949477
Location
Coordinates40.7650502°N 73.9600540°W / 40.7650502; -73.9600540
Websitewww.nybloodcenter.org

NYBC, along with its operating divisions Community Blood Center of Kansas City, Missouri (CBC),[4] Innovative Blood Resources (IBR),[5] Blood Bank of Delmarva (BBD),[6] and Rhode Island Blood Center (RIBC),[7] collect approximately 4,000 units of blood products each day and serve local communities of more than 75 million people in the Tri-State area (NY, NJ, CT), Mid Atlantic area (PA, DE, MD, VA), Missouri and Kansas, Minnesota, Nebraska, Rhode Island, and Southern New England.

In addition to serving the New York City metropolitan area, New Jersey, Connecticut and Pennsylvania, in May 2014, NYBC merged its operations with Community Blood Center of Greater Kansas City (CBC).[8] In February 2016, NYBC and CBC announced the creation of the Kansas City-based National Center for Blood Group Genomics, a new laboratory that will focus on precision testing of blood donor samples.[9]

NYBC maintains close relationships with both New York City's Police Department (NYPD) and Fire Department (FDNY). Among NYBC's largest donor groups is the NYPD, which donated more than 11,000 pints of blood through November 2015.[10] At the same time, the FDNY participates with NYBC in the "Be The Match Program" operated by the National Marrow Donor Program (NMDP).[11] More than 8,000 FDNY members are on the potential donor list, and 179 members have already given this life saving gift to those in need. FDNY members represent more than 10% of all NYBC bone marrow donors.[12] Each year, at an annual induction ceremony hosted by FDNY and NYBC at FDNY headquarters, donors and their recipients meet for the first time.[13] In 2016, Firefighter Mike Wilson was introduced to a recipient from Erie, Pennsylvania, who received his lifesaving bone marrow to treat her acute myeloid leukemia (AML), while Firefighter Frank Perdue met a recipient diagnosed with essential thrombocythemia, a rare chronic blood disorder.[14] In 2015, firefighter Michael McCauley of Staten Island met his recipient, a United States Marine Sergeant who saw combat in Iraq, and who was subsequently diagnosed with acute myeloid leukemia (AML). Through FDNY’s participation in NYBC’s program, McCauley’s bone marrow is credited with saving the recipient's life.[15]

NYBC houses Lindsley F. Kimball Research Institute and the Howard P. Milstein National Cord Blood Center, a public cord blood bank named after board member Howard Milstein. The National Cord Blood Program (NCBP), directed by Dr. Pablo Rubinstein, is the oldest and largest in the world.[16] In August 2015, the NCBP announced a new collaboration with the University of California, Davis Health System to manufacture specialized lines of highly adaptable stem cells for potential new therapies for diseases that include anemia, leukemia, lymphoma, sickle cell disease and severe combined immunodeficiency.[17]

The Lindsley F. Kimball Research Institute (LFKRI) has been awarded grants to conduct research in such areas as epidemiology and the development of HIV self-testing interventions, cellular therapy and transfusion medicine, in vitro platelet production, blood genomics, immunology, the development of infectious disease screening techniques and preventions for diseases like severe acute respiratory syndrome, Hepatitis B and Hepatitis C.[18][19][20][21][22][23][24]

History

In 2013, LFKRI was awarded a Grand Challenges Explorations Grant from a grant initiative engaging field leaders in global health to bring progress to targeted world problems. The Grand Challenges Explorations Grant was launched by the Bill and Melinda Gates Foundation in 2007.[25] The LFKRI used grant money to study the transmission of parasites from Filarial Worm larvae to humans in order to develop a preventative drug to kill mature worms and prevent parasitic infection.[26]

In 2014, the New York Blood Center's National Cord Blood Program (NCBP) at the Howard P. Milstein Cord Blood Center received the Prix Galien USA “Best Biotechnology Product” distinction for the development of HEMACORD, an innovative hematopoietic stem cell product and the first of its kind to be approved by the Food and Drug Administration.[27]

In August 2016, NYBC also combined operations with Innovative Blood Resources, a blood center with operations in Minnesota and Nebraska.[28]

LFKRI also oversaw a clinical trial of Immucor’s PreciseType HEA test, resulting in the approval of the product by the FDA in October 2016.[29] The PreciseType HEA test screens blood donors for sickle cell trait (SCT), an inherited blood disorder that affects 1 million to 3 million Americans, including 8-10% of African Americans.[30] PreciseType HEA is the only FDA-approved molecular test that provides clinicians and blood banks with detailed genetic matching information. Through its work with cord blood, stem cells and sickle cell treatments, NYBC is a leader in precision medicine, which takes into account individual variability in genes, environment, and lifestyle to more accurately match treatments to individual patients.[31][32]

Rhode Island Blood Center, Providence

In 2019, New York Blood Center merged with the Rhode Island Blood Center (RIBC). The latter continues to do business as the Rhode Island Blood Center.[33]

In 2020 New York Blood Center was the first blood center to collect convalescent blood plasma donations from people who have recovered from COVID-19 to treat other patients with advanced illness.[34] On March 27, 2020, the first unit of convalescent blood plasma was drawn.[35] In convalescent plasma treatment, the patient is transfused with the plasma from a recovered COVID-19 patient with the goal of using the donor’s antibodies to help clear the virus more rapidly.[36] In January 2021, research by the Mayo Clinic validated the use of convalescent plasma treatment for COVID-19 patients amid widespread vaccine shortages.[37][38]

Primate research in Liberia

For a thirty-year period starting in the mid-1970s, the New York Blood Center conducted research experiments on a group of chimpanzees in Liberia. At the time, such primate testing was considered a standard part of medical research and drug development.[39] After the studies were complete in 2004, NYBC moved the survivors onto six islands on the Farmington River in Liberia.[40] Though NYBC continued to financially support the sanctuary for almost a decade at a cost of around $30,000 a month, they stopped in March 2015.[41]

The situation set off a storm of protests by animal rights and animal welfare advocates, and NYBC said they received threats and social media campaigns which personally threatened their employees.[42][43][41] On March 31, 2016, Citigroup issued a statement that "the current situation is not tolerable and we urge all parties involved to come up with a sustainable solution to ensure that these chimpanzees get the care they need."[44] On May 19, New York State Senator Tony Avella held a press conference at New York City Hall to demand that NYBC fulfill its promise to provide lifelong care for the chimpanzees.[41]

NYBC had asserted that the animals were owned by the Liberian government, and Liberian officials had repeatedly acknowledged their own responsibility for the care of the chimpanzees.[40][45] Though NYBC voluntarily supported the chimps for years after its relationship with the Liberian government ended,[42] they had spent millions of dollars on the chimps since the mid-2000s while repeatedly reaching out to the Liberian government and animal rights groups attempting to find a long term solution.[46]

The New York Times had quoted Dr. Alfred Prince's 2005 article seeking primatologists and/or foundations to take over the care of the chimpanzees. In the article, Prince had written that NYBC "recognizes its responsibility to provide an endowment to fund the Sanctuary for the lifetime care of the chimpanzees." However, NYBC spokeswoman Victoria O'Neill responded that Prince had not been authorized to say that, that NYBC "did not ever establish any endowment for animal care, chimpanzees included," and "never had any obligation for care for the chimps, contractual or otherwise."[47][45]

The Humane Society of the United States (HSUS) took over supporting the chimps, and started a campaign to raise funds for them.[45] Negotiations between NYBC and HSUS in 2016 were unsuccessful, with NYBC maintaining that they had been confronted with requests that "have nothing to do with NYBC's original involvement in Liberia."[42][46] However, in 2017 NYBC and HSUS came to an agreement with NYBC pledging $6 million directly to HSUS, who would assume responsibility for the lifetime care of the chimps.[43]

References
  1. "Healthcare Providers and Services Company Overview of New York Blood Center, Inc". Bloomberg. 19 August 2016. Retrieved 19 August 2016.
  2. "Aaron Kellner, 78, Who Created A Blood-Supply Network, Is Dead". New York Times. 12 December 1992. Retrieved 19 August 2016.
  3. Hartocollis, Anemona (January 28, 2015). "New York Blood Donations Are Sought After Storm Disrupts Giving". New York Times. Retrieved June 29, 2015.
  4. "New York Blood Center and Community Blood Center Merge as One Organization | New York Blood Center".
  5. "Innovative Blood Resources and New York Blood Center Complete Merger | Memorial Blood Centers".
  6. "Blood Bank of Delmarva and New York Blood Center Join Forces | Blood Bank of Delmarva".
  7. "RIBC and NYBC Merge | Rhode Island Blood Center".
  8. Bavley, Alan (12 May 2014). "Community Blood Center of KC to merge with New York counterpart". The Kansas City Star. Retrieved 19 August 2016.
  9. Grote, Dora (5 February 2016). "Be positive: National blood center lands in KC". Kansas City Business Journal. Retrieved 19 August 2016.
  10. Parascandola, Rocco (30 December 2015). "NYPD cops put the blood in "blood, sweat and tears"". Daily News New York. Retrieved 26 August 2016.
  11. "About Be The Match". Be The Match. Retrieved 26 August 2016.
  12. FDNY Press Office (29 April 2016). "Fire Commissioner and New York Blood Center Honor FDNY Bone Marrow Donors". Fire Department City of New York. Retrieved 26 August 2016.
  13. CBS New York (29 January 2014). "FDNY Honors Life-Saving Bone Marrow Donors". CBS New York. Retrieved 6 October 2016.
  14. Daily News (29 April 2016). "Bone marrow recipients to meet FDNY donors". Daily News. Retrieved 6 October 2016.
  15. Staten Island Advance (4 March 2015). "Staten Island firefighter helps save a stranger's life by donating his bone marrow". silive.com. Retrieved 6 October 2016.
  16. Rubin, Rita (13 July 2005). "Young lives get a fighting chance". Retrieved 26 August 2016 – via USA Today.
  17. "Cord blood's promise: UCD labs are helping harness valuable inventory". The Davis enterprise. 15 July 2016. Retrieved 26 August 2016.
  18. Lee, Steve (17 September 2014). "New York Blood Center receives $2 million in NIDA funding to develop HIV self-testing intervention". LGBT Weekly. Retrieved 22 November 2016.
  19. Acton, Ashton (2013). "Lindsley F Kimball Research Institute, New York City: Correlates of Unprotected Vaginal or Anal Intercourse with Women Among Substance-Using Men Who Have Sex with Men". HIV/AIDS: New Insights for the Healthcare Professional: 2013 Edition. ScholarlyEditions. ISBN 9781481665360 – via Google Books.
  20. Acton, Ashton (2013). "Lindsley F. Kimball Research Institute, New York City: Interactions between different generation HIV-1 fusion inhibitors and the putative mechanism underlying the synergistic anti-HIV-1 effect resulting from their combination". Sexually Transmitted Diseases - Advances in Research and Application: 2013 Edition. ScholarlyEditions. ISBN 9781481680141 – via Google Books.
  21. Chustecka, Zosia (10 November 2014). "Cord Blood: From Medical Waste to Award-winning Product". MedScape Medical News. Retrieved 22 November 2016.
  22. Acton, Ashton (2013). "Lindsley F Kimball Research Institute, New York City: Optimizing megakaryocyte polyploidization by targeting multiple pathways of cytokinesis". Bone Marrow Cells - Advances in Research Application: 2013 Edition. ScholarlyEditions. ISBN 9781481698047 – via Google Books.
  23. Liu, Phillip Z.; Huang, Cheng-Han (2000). "Blood Group Antigens: Molecular Biology, Functions, and Clinical Applications". Seminars in Hematology. Elsevier. 37 (2): 150–165. doi:10.1016/S0037-1963(00)90040-4. PMID 10791884.
  24. Acton, Ashton (2011). "Lindsley F. Kimball Research Institute, New York City: Recombinant receptor-binding domain of SARS-CoV spike protein expressed in mammalian, insect and E. coli cells elicits potent neutralizing antibody and protective immunity". Immunoproteins: Advances in Research and Application: 2011 Edition. ScholarlyEditions. ISBN 9781464922534 – via Google Books.
  25. Bill & Melinda Gates Foundation. "New Grants Initiative to Spur Innovative Research in Global Health". Gates Foundation. Retrieved 22 November 2016.
  26. "New York Blood Center's Research Institute Receives Grand Challenges Explorations Grant For Groundbreaking Research in Global Health and Development". Bio-Medicine. 21 May 2013. Retrieved 22 November 2016.
  27. Chustecka, Zosia (10 November 2014). "Cord Blood: From Medical Waste to Award-winning Product". Medscape Medical News. Retrieved 22 November 2016.
  28. "Biz buzz for Aug. 8". Duluth News Tribune. 8 August 2016. Retrieved 19 August 2016.
  29. "FDA approves Immucor's PreciseType® HEA Test to be used for screening blood donors for Sickle Cell Trait (SCT)". Nasdaq. 21 October 2016. Retrieved 22 November 2016.
  30. "Sickle Cell Trait". American Society of Hematology. Retrieved 22 November 2016.
  31. Semedo, Daniela (8 November 2016). "FDA Approves Immucor's PreciseType HEA Test to Screen for Sickle Cell Trait". Sickle Cell Anemia News. Retrieved 22 November 2016.
  32. "What is precision medicine?". NIH U.S. National Library of Medicine: Genetics Home Reference. Retrieved 22 November 2016.
  33. LeBlanc, Kara. "RIBC and NYBC Merge". Rhode Island Blood Center. Rhode Island Blood Center. Retrieved 17 October 2020.
  34. "Blood centers will collect plasma from COVID-19 survivors in bid for treatment".
  35. Grady, Denise (26 March 2020). "Blood Plasma from Survivors Will be Given to Coronavirus Patients". The New York Times.
  36. Marano, Giuseppe; Vaglio, Stefania; Pupella, Simonetta; Facco, Giuseppina; Catalano, Liviana; Liumbruno, Giancarlo M.; Grazzini, Giuliano (2016). "Convalescent plasma: new evidence for an old therapeutic tool?". Blood Transfusion. 14 (2): 152–157. doi:10.2450/2015.0131-15. PMC 4781783. PMID 26674811.
  37. "Mayo validates COVID-19 plasma treatment as public seeks vaccine".
  38. Wu, Katherine J. (6 January 2021). "Blood Plasma Reduces Risk of Severe Covid-19 if Given Early". The New York Times.
  39. Rowan, A.N.; Loew, F.M. (2001). "Animal research: A review of developments, 1950-2000". In Salem, D.J.; Rowan, A.N. (eds.). The state of the animals 2001. Washington, DC: Humane Society Press. pp. 111–120.
  40. McAfee, Melonyce (11 September 2015). "Chimps in need after U.S. organization withdraws care". CNN.
  41. "Protesters rally for chimpanzees in Liberia". WNYW. 19 May 2016.
  42. Simmons, Keir (5 September 2016). "Rescuers help abandoned chimps used in medical experiments". Retrieved 20 October 2016 – via Today.
  43. Gorman, James (May 30, 2017). "New York Blood Center Reaches a Deal to Help Care for Research Chimps". The New York Times. Retrieved January 30, 2023.
  44. Skyler, Ed (2016-03-31). "Our Statement on the Care of Chimpanzees in Liberia". Citigroup.
  45. Gorman, James (28 May 2015). "Chimpanzees in Liberia, Used in New York Blood Center Research, Face Uncertain Future". Retrieved 20 October 2016 – via The New York Times.
  46. Christie, Megan (30 September 2016). "Lab Chimps 'Abandoned' on African Island, Activists Say". Retrieved 20 October 2016 – via ABC News. The NYBC has maintained that it has already spent millions on the chimps since its deal with the Liberian government ended in the mid-2000s and can no longer afford to divert money from essential programs that save thousands of human lives. In response to questions from ABC News, NYBC Vice President Robert Purvis slammed the HSUS and said the NYBC tried to work with the group for months and were confronted with requests that "have nothing to do with NYBC's original involvement in Liberia." Purvis said the NYBC "repeatedly" reached out to the animal rights community and the Liberian government "in an attempt to assist in a long-term solution for Liberia's chimps." "NYBC was ignored," he said.
  47. Prince, Alfred M (December 2005). "Leadership Sought for Chimpanzee Sanctuary in Liberia" (PDF). American Society of Primatologists. Retrieved January 30, 2023.
This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.